Department of Medicine
Faculty Profiles by Division

Division of Gastroenterology, Hepatology and Nutrition

Faculty Profiles

[Return To Index page]
photo Shari S. Rogal, MD, MPH

Gastroenterology

Associate Professor of Medicine and Surgery

Co-Director, Implementation Core - Center for Health Equity Research and Promotion - VAPHS

Staff Physician, VA Pittsburgh Healthcare System

Co-Director, Dissemination and Implementation Science Collaborative - Clinical and Translational Science Institute

Co-Director, IMPACT and Implementation Lab Cores - Clinical and Translational Science Institute

Email: rogalss@upmc.edu

Phone: 866-482-7488

Contact
Office: Div. of GI, Hepatology & Nutrition
VA HealthCare Systems
Pittsburgh, PA 15213
 
Phone: 866-482-7488
Fax:
E-mail: rogalss@upmc.edu
Administrative Assistant:
Sarah Gibson
Address: VAPHS
Pittsburgh, PA
Email: Sandra.Gibson2@va.gov
Phone: 412-360-6611
Education and Training
Education
BS, Yale University, 2001
MD, Yale University School of Medicine, 2006
MPH, Yale University School of Epidemiology and Public Health, 2006
Training
Internal Medicine Internship and Residency, Brigham and Women's Hospital, 2009
Gastroenterolgy, Hepatology, and Nutrition Fellowship, University of Pittsburgh, 2013
Transplant Hepatology Fellowship, University of Pittsburgh, 2014
Research Interest
As an adjunct assistant professor of medicine, Dr. Rogal brings her extensive, collaborative experience with Transplant Surgery and the VA Healthcare System to the Division of Gastroenterology, Hepatology and Nutrition. Dr. Rogal studies liver transplant outcomes with particular interests in addiction and pain with chronic liver disease patients. She is also interested in the implementation of science to combat health disparities.
Clinical Interest
Hepatology.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Rogal, S.S., Landsittel, D., Surman, O., Chung, R., Rutherford, A. Pretransplant Depression, Antidepressant Use, and Outcomes of Orthotopic Liver Transplantation. Liver Transplantation. 2011; 17(3): 251-60.
Rogal, S.S., Pinsky, P.F., Schoen, R.E. Relationship between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer. Clinical Gastroenterology and Hepatology. 2013; 11(1): 73-8.
Rogal, S.S., Dew, M.A., Fontes, P., DiMartini, A.F. Early Treatment of Depressive Symptoms and Long-Term Survival after Liver Transplantation. American Journal of Transplantation. 2013; 13(4): 928-35.
Rogal, S.S., Winger, D., Bielefeldt, K., Szigethy, E. Pain and Opioid Use in Chronic Liver Disease. Digestive Diseases and Sciences. 2013; 58(10): 2976-85.
Rogal, S.S., Winger, D., Bielefeldt, K., Rollman, B.F., Szigethy, E. Healthcare Utilization in Chronic Liver Disease: the Role of Pain and Opioid Use. Liver International. 2013; 33(10): 1497-503.
Rogal, S.S., Wasan, A., Bielefeldt, K., Lotrich, F., Zickmund, S., Szigethy, E., DiMartini, A. Inflammation, Psychiatric Symptoms, and Opioid Use are Associated with Pain and Disability in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology. 2015; 13(5): 1009-16.
Butt, A.A., Yan, P., Bonilla, H., Abou-Samra, A.B., Shaikh, O.S., Simon, T.G., Chung, R.T., Rogal, S.S. Effect of the Addition of Statins to Antiviral Therapy in HCV Infected Persons: Results of ERCHIVES. Hepatology. 2015; 62(2): 365-74.
Rogal, S.S., Yan, P., Rimland, D., Lo Re, V., Al-Rowais, H., Fried, L., Butt, A.A. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion. 2015.
Chidi, A., Rogal, S.S., Bryce, C.L., Fine, M.J., Good, C.B., Myaskovsky, L., Rustgi, V., Tsung, A., Smith, K.J. Cost-Effectiveness of New Antiviral Regimens for Treatment-Naive US Veterans with Hepatitis C. Hepatology. 2016; 63(2): 428-36.
Rogal, S.S., Arnold, R.A., Chapko, M.K., Hanusa, B.V., Youk, A., Switzer, G.E., Sevick, M.A., Bayliss, N.K., Zook, C.L., Chidi, A., Obrosky, D.S., Zickmund, S.L. The Patient-Provider Relationship is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study. PlosOne. 2016.
Sponsored Research/Activities
Title: Improving Pain Management and Opioid Safety for Patients with Cirrhosis
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: K23 DA048182
Start Year: 2020
End Year: 2024
Title: IPA - SANDRA GIBSON
Role: Principal Investigator
Funding Agency: Veterans Research Foundation of Pittsburgh
Grant Number: IPA
Start Year: 2020
End Year: 2021